Časopisy s impakt faktorem

NOVOTNÝ, J., M. CARNA, E. DAMMER, Z. MAO, G. STOKIN

Rethinking Alzheimer's: novel miRNAs illuminate a disease beyond the brain. Molecular Psychiatry. 2026, ISSN: 1359-4184, PMID: 41688789, PDF.

ŽÁRSKÁ, L., M. GAPCOVA, Z. CHALOUPKOVA, V. RANC

CD44 receptor-driven graphene oxide based nanocarriers for cancer therapy. Biomedicine & Pharmacotherapy. 2026, 195, 19036, ISSN: 0753-3322, PMID: 41604892, PDF.

SIEGL, F., E. GARCIA-BORJA, R. MATEU, K. TRACHTOVA, M. JASIK, M. KOPECKY, M. VECERA, L. RADOVÁ, M. HENDRYCH, T. KAZDA, P. FADRUS, A. SEDO, O. SLABÝ, P. BUSEK, J. ŠÁNA

Differential Expression of PIWI-interacting RNAs in Glioblastoma Stem Cells Affects Their Biological Features: Implications for Tumor Progression and Patient Survival. lab. 2026, Jan 13, 106072, ISSN: 0023-6837, PMID: 41539389,

SUDZINOVA, P., T. KNEZOVA BALOGOVA, M. SCHWARZ, K. JURIKOVA MIKESKOVA, K. HEGROVA, D. VITOVSKA, P. RAWAT, S. BOBKOVA, V. KOCARKOVA, S. NATARAJAN, D. POSPISILOVA, A. KRENKOVA, M. HUBALEK, P. HALADA, I. BARVIK, T. KOVAL, J. DOHNALEK, J. WIEDERMANNOVA, H. SANDEROVA, L. KRASNY

Bacteria sense the antibiotic rifampicin through a widespread dual-promoter based alarm system. Nucleic Acids Research. 2026, 54(2), gkaf1407, ISSN: 0305-1048, PMID: 41533585. PDF.

KHOSRAVIFARD, S., S. HOSSEINKHANI, N. BAKHTIARY, M. PEYVANDI, A. DÖMLING

Disruption of NLRP3 inflammasome assembly via ligand-induced remodeling of pyrin domain interfaces. Scientific Reports. 2026, ISSN: 2045-2322, PMID: 41513945, PDF.

VESELA, K., A. TATAR, Z. KEJIK, N. ABRAMENKO, R. KAPLANEK, P. BABULA, K. KUCNIROVA, J. HAJDUCH, P. MARTASEK, M. JAKUBEK

Ruthenium-enhanced curcumin derivatives target tumor growth and cancer-related inflammation in head and neck cancer models. Frontiers in Oncology. 2025, 15, 1708944, ISSN: 2234-943X, PMID: 41479792, PDF.

VESELA, K., A. TATAR, Z. KEJIK, N. ABRAMENKO, J. CEJKA, R. KAPLANEK, M. MASARIK, P. BABULA, P. MARTASEK, M. JAKUBEK

Targeting tumors and inflammation: A quinoline-chalcone ruthenium complex with therapeutic promise. Biomedicine & pharmacotherapy. 2026, 194, 118930, ISSN: 0753-3322, PMID: 41421207, PDF.

SHOMAN, M., M. CERNY, J. JIRAT MATEJCKOVA, M. SCHWARZ, N. BORAH, V. VANKOVA HAUSNEROVA, S. NEVA, M. SIKOVA, H. SANDEROVA, P. HALADA, M. HUBALEK, V. DVORAKOVA, M. PREVOROVSKY, J. HOLUBOVA, O. STANEK, L. KRASNY, L. ZIDEK, J. HNILICOVA

Expanding the CarD interaction network: CrsL is a novel transcription regulator in actinobacteria. Nucleic Acids Research. 2025, 53(22), gkaf1342, ISSN: 0305-1048, PMID: 41404806, PDF.

AHMAD, J., P. SEBO

Producing Trojans: hijacking of monocyte differentiation by pathogens. Trends in Microbiology. 2025, S0966-842X(25), 00362-2, ISSN: 0966-842X, PMID: 41390247,

TANGALLAPALLI, S., R. GUNDLA, K. PAIDIKONDALA, S. GURSKÁ, N. RAMPEESA, S. ANUGU, P. DŽUBÁK, M. HAJDÚCH, V. DAS, N. KATARI

Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors. RSC advances. RSC Advances. 2025, 15(55), 47565-47586, ISSN: 2046-2069, PMID: 41356712,